Literature DB >> 20151132

The effect of obstruction and perforation on colorectal cancer disease-free survival.

Yik-Hong Ho1, Simon K K Siu, Petra Buttner, Andrew Stevenson, John Lumley, Russel Stitz.   

Abstract

BACKGROUND: Obstruction (OBSTR) and perforation (PERF) in colorectal cancer impact adversely upon outcomes, and cancer-related survival may also be affected. However, data are sparse, particularly on disease-free survival (DFS) where the cancer is both obstructed and perforated (OBS-PERF).
METHODS: Data were extracted from a prospectively collected database of 1876 colorectal cancer patients managed and followed up at the Royal Brisbane Hospital from 1984 to 2004. The patients who had curative surgery (n = 1426) were classified as OBSTR (n = 153), PERF (n = 53), OBS-PERF (n = 19), and uncomplicated (UNCOM; n = 1201). Kaplan-Meier survival and Cox proportional hazard analyses were performed.
RESULTS: Postoperative mortality within 30 days of surgery was 1.5% (n = 22) and the overall complication rate was 40.8% (n = 582). However, only 7.2% (n = 102) required reoperations. The median survival time was 71 (IQR = 64.9-77.1) months and the median follow-up for DFS was 37.5 (IQR 14-68) months. The overall recurrence rate was 32.7% (n = 466), the local recurrence rate was 9.4% (n = 135), and local and distant recurrences occurred in the same patient in 4.7% (n = 67). Male gender, OBSTR, PERF, OBS-PERF, emergency operation, major medical and surgical complications, reoperation, TNM staging, tumor grading, and tumor venous invasion adversely affected DFS (p < 0.05). Multivariate analysis showed that OBS-PERF (p = 0.008), major medical complications (p = 0.011), reoperation (p = 0.018), TNM staging (p < 0.001), grading (p = 0.018), and venous invasion (p = 0.002) were independently associated with a poorer DFS.
CONCLUSIONS: OBS-PERF colorectal cancer is associated with a poorer DFS, which may be worse than either OBSTR or PERF alone.

Entities:  

Mesh:

Year:  2010        PMID: 20151132     DOI: 10.1007/s00268-010-0443-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  36 in total

1.  Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.

Authors:  H S Chen; S M Sheen-Chen
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

2.  Management of severe obstruction of the large bowel due to malignant disease.

Authors:  J P Welch; G A Donaldson
Journal:  Am J Surg       Date:  1974-04       Impact factor: 2.565

3.  Surgery may be curative for patients with a localized perforation of rectal carcinoma.

Authors:  F H Kagda; D C Nyam; Y H Ho; K W Eu; A F Leong; F Seow-Choen
Journal:  Br J Surg       Date:  1999-11       Impact factor: 6.939

4.  Risk factors in patients presenting as an emergency with colorectal cancer.

Authors:  N A Scott; J Jeacock; R D Kingston
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

5.  The treatment of colonic cancer presenting with intestinal obstruction.

Authors:  T T Irvin; M G Greaney
Journal:  Br J Surg       Date:  1977-10       Impact factor: 6.939

6.  Outcome of large-bowel perforation in patients with colorectal cancer.

Authors:  P G Carraro; M Segala; C Orlotti; G Tiberio
Journal:  Dis Colon Rectum       Date:  1998-11       Impact factor: 4.585

7.  Systemic inflammatory response predicts survival following curative resection of colorectal cancer.

Authors:  D C McMillan; K Canna; C S McArdle
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

8.  Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.

Authors:  R Yancik; M N Wesley; L A Ries; R J Havlik; S Long; B K Edwards; J W Yates
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

9.  A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery.

Authors:  D C McMillan; H A Wotherspoon; K C Fearon; C Sturgeon; T G Cooke; C S McArdle
Journal:  Am J Surg       Date:  1995-10       Impact factor: 2.565

10.  Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection.

Authors:  Ze-Yu Wu; Jin Wan; Gang Zhao; Lin Peng; Jia-Lin Du; Yuan Yao; Quan-Fang Liu; Hua-Huan Lin
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

View more
  13 in total

1.  Postoperative Complications Predict Long-term Outcome After Curative Resection for Perforated Colorectal Cancer.

Authors:  Shintaro Hashimoto; Kiyoaki Hamada; Yorihisa Sumida; Masato Araki; Kouki Wakata; Tota Kugiyama; Ayako Shibuya; Masato Nishimuta; Shigeyuki Morino; Masayuki Baba; Soichiro Kiya; Keisuke Ozeki; Akihiro Nakamura
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Young colorectal cancer patients often present too late.

Authors:  Jia-Hao Law; Frederick H Koh; Ker-Kan Tan
Journal:  Int J Colorectal Dis       Date:  2017-05-18       Impact factor: 2.571

3.  Clinicopathologic characteristics and outcomes of patients with obstructive colorectal cancer.

Authors:  Zuli Yang; Lei Wang; Liang Kang; Jun Xiang; Junsheng Peng; Ji Cui; Yihua Huang; Jianping Wang
Journal:  J Gastrointest Surg       Date:  2011-05-17       Impact factor: 3.452

4.  Optimal use of adjuvant chemotherapy in stage II colorectal cancer.

Authors:  Zhongguo Zhou; Xiaojun Wu; Ruojing Wang; Liren Li; Zhenhai Lu; Gong Chen; Yujing Fang; Zhizhong Pan
Journal:  Int J Colorectal Dis       Date:  2011-03-24       Impact factor: 2.571

5.  Emergency transanal total mesorectal excision for perforated rectal cancer: a two-case series.

Authors:  Hiroya Enomoto; Katsuhito Suwa; Nana Takeuchi; Yuhei Tsukazaki; Takuro Ushigome; Tomoyoshi Okamoto; Ken Eto
Journal:  Surg Case Rep       Date:  2022-06-22

6.  Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.

Authors:  Kotaro Sugawara; Yoshikuni Kawaguchi; Yukihiro Nomura; Daisuke Koike; Motoki Nagai; Nobutaka Tanaka
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

7.  Treatment of perforated colon carcinomas-outcomes of radical surgery.

Authors:  M Daniels; S Merkel; A Agaimy; W Hohenberger
Journal:  Int J Colorectal Dis       Date:  2015-08-07       Impact factor: 2.571

8.  Curative treatment for metastatic colorectal cancer in the young population: is it worth it?

Authors:  Jia Hao Law; Frederick Hong Xiang Koh; Shi Wang; Ker Kan Tan
Journal:  J Gastrointest Oncol       Date:  2019-02

9.  Outcome of colon cancer initially presenting as colon perforation and obstruction.

Authors:  Tsung-Ming Chen; Yen-Ta Huang; Guan-Chyuan Wang
Journal:  World J Surg Oncol       Date:  2017-08-25       Impact factor: 2.754

10.  Missed opportunities: racial and neighborhood socioeconomic disparities in emergency colorectal cancer diagnosis and surgery.

Authors:  Sandi L Pruitt; Nicholas O Davidson; Samir Gupta; Yan Yan; Mario Schootman
Journal:  BMC Cancer       Date:  2014-12-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.